Kerri-Ann Millar - Jun 5, 2024 Form 4 Insider Report for Cue Biopharma, Inc. (CUE)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Kerri-Ann Millar by Colin Sandercock, attorney-in-fact
Stock symbol
CUE
Transactions as of
Jun 5, 2024
Transactions value $
$0
Form type
4
Date filed
6/7/2024, 04:00 PM
Previous filing
Mar 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CUE Stock Option (right to buy) Award $0 +60K $0.00 60K Jun 5, 2024 Common Stock 60K $1.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option becomes exercisable in eight equal semi-annual installments beginning on December 5, 2024.